Patients with de novo AML are found to have a chromosomal translocation of the mixed lineage leukemia gene located at chromosome band 11q23 (Cierpicki and Grembecka, 2014), a chromosomal translocation that results in the fusion of the MLL gene with one of over 60 different protein partners (Prange et al., 2017), with the AF9 protein being a common fusion partner in mixed lineage leukemia (Prange et al., 2017). This evidence concerns the gene KMT2A and leukemia.